Literature DB >> 16153659

Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.

L G de Pillis1, W Gu, A E Radunskaya.   

Abstract

We develop and analyze a mathematical model, in the form of a system of ordinary differential equations (ODEs), governing cancer growth on a cell population level with combination immune, vaccine and chemotherapy treatments. We characterize the ODE system dynamics by locating equilibrium points, determining stability properties, performing a bifurcation analysis, and identifying basins of attraction. These system characteristics are useful not only to gain a broad understanding of the specific system dynamics, but also to help guide the development of combination therapies. Numerical simulations of mixed chemo-immuno and vaccine therapy using both mouse and human parameters are presented. We illustrate situations for which neither chemotherapy nor immunotherapy alone are sufficient to control tumor growth, but in combination the therapies are able to eliminate the entire tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153659     DOI: 10.1016/j.jtbi.2005.06.037

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  64 in total

1.  Global Dynamics of a Breast Cancer Competition Model.

Authors:  Kristen Abernathy; Zachary Abernathy; Arden Baxter; Meghan Stevens
Journal:  Differ Equ Dyn Syst       Date:  2017-01-20

2.  Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape.

Authors:  Li Wenbo; Jin Wang
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

3.  Optimization of combination therapy for chronic myeloid leukemia with dosing constraints.

Authors:  Helen Moore; Lewis Strauss; Urszula Ledzewicz
Journal:  J Math Biol       Date:  2018-07-10       Impact factor: 2.259

4.  Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions.

Authors:  H Hatzikirou; J C L Alfonso; S Mühle; C Stern; S Weiss; M Meyer-Hermann
Journal:  J R Soc Interface       Date:  2015-11-06       Impact factor: 4.118

5.  A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy.

Authors:  Shelby Wilson; Doron Levy
Journal:  Bull Math Biol       Date:  2012-03-22       Impact factor: 1.758

6.  Modelling lymphoma therapy and outcome.

Authors:  Katja Roesch; Dirk Hasenclever; Markus Scholz
Journal:  Bull Math Biol       Date:  2013-12-14       Impact factor: 1.758

7.  Mathematical modeling of cancer-immune system, considering the role of antibodies.

Authors:  Sumana Ghosh; Sandip Banerjee
Journal:  Theory Biosci       Date:  2018-03-23       Impact factor: 1.919

8.  Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.

Authors:  Natalie Kronik; Yuri Kogan; Moran Elishmereni; Karin Halevi-Tobias; Stanimir Vuk-Pavlović; Zvia Agur
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  Chemotherapy in conjoint aging-tumor systems: some simple models for addressing coupled aging-cancer dynamics.

Authors:  Mitra S Feizabadi; Tarynn M Witten
Journal:  Theor Biol Med Model       Date:  2010-06-15       Impact factor: 2.432

Review 10.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.